These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7720986)

  • 1. [Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study].
    Dorval ED; Regimbeau C; Gamelin E; Picon L; Bérard H
    Gastroenterol Clin Biol; 1995 Jan; 19(1):27-30. PubMed ID: 7720986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea.
    Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
    Gut; 1992 Jun; 33(6):753-8. PubMed ID: 1624154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide.
    Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM
    Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.
    Beaugerie L; Baumer P; Chaussade S; Berard H; Rozenbaum W; Pialoux G; Le Quintrec Y; Schwartz JC; Lecomte JM
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):485-9. PubMed ID: 8804878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].
    Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
    Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638
    [No Abstract]   [Full Text] [Related]  

  • 7. Racecadotril in the treatment of acute watery diarrhea in children.
    Salazar-Lindo E; Santisteban-Ponce J; Chea-Woo E; Gutierrez M
    N Engl J Med; 2000 Aug; 343(7):463-7. PubMed ID: 10944563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E; Hidalgo M; Hornedo J; Cortés-Funes H
    Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
    François E; Berdah JF; Chamorey E; Lesbats G; Teissier E; Codoul JF; Badetti JL; Hébert C; Mari V
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):931-6. PubMed ID: 18273618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
    Wolff K; Wein A; Reulbach U; Männlein G; Brückl V; Meier C; Ostermeier N; Schwab SA; Horbach T; Hohenberger W; Hahn EG; Boxberger F
    Anticancer Drugs; 2009 Mar; 20(3):165-73. PubMed ID: 19125117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction. Enkephalinase inhibition: a rational approach to antisecretory therapy for acute diarrhoea.
    Farthing MJ
    Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():1-2. PubMed ID: 10646044
    [No Abstract]   [Full Text] [Related]  

  • 13. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.
    Saliba F; Hagipantelli R; Misset JL; Bastian G; Vassal G; Bonnay M; Herait P; Cote C; Mahjoubi M; Mignard D; Cvitkovic E
    J Clin Oncol; 1998 Aug; 16(8):2745-51. PubMed ID: 9704727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
    Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
    Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of racecadotril and single dose octreotide as an anti-secretory agent in acute infective diarrhoea.
    Mehta S; Khandelwal PD; Jain VK; Sihag M
    J Assoc Physicians India; 2012 Nov; 60():12-5. PubMed ID: 23767196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.